- EAN13
- 9782742016556
- Éditeur
- John Libbey
- Date de publication
- 10/2020
- Langue
- anglais
- Fiches UNIMARC
- S'identifier
Autre version disponible
-
Papier - John Libbey 28,00
There has been growing interest in the use of cannabis-based products for the
treatment of a wide range of diseases, including epilepsy. A number of studies
were published during the last 5 years
demonstrating efficacy of purified CBD for the control of a large spectrum of
seizure-types, particularly those observed in severe childhood epilepsies,
such as Lennox- Gastaut and Dravet syndromes. This book, co-authored by
leaders in the field of epileptology, critically reviews recent data from
clinical trials. Authors discuss issues related to pharmacology, drug
interactions, efficacy, potential adverse events and
long-term effects on development and behaviour. Child and adult neurologists
and all clinicians contributing to epilepsy care will find useful information
on the best practices, when using purified CBD for the treatment of
drug-resistant epilepsies.
treatment of a wide range of diseases, including epilepsy. A number of studies
were published during the last 5 years
demonstrating efficacy of purified CBD for the control of a large spectrum of
seizure-types, particularly those observed in severe childhood epilepsies,
such as Lennox- Gastaut and Dravet syndromes. This book, co-authored by
leaders in the field of epileptology, critically reviews recent data from
clinical trials. Authors discuss issues related to pharmacology, drug
interactions, efficacy, potential adverse events and
long-term effects on development and behaviour. Child and adult neurologists
and all clinicians contributing to epilepsy care will find useful information
on the best practices, when using purified CBD for the treatment of
drug-resistant epilepsies.
S'identifier pour envoyer des commentaires.